Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

22 Oct 2018 Evaluate

Alembic Pharmaceuticals has informed about press release, titled 'Alembic Pharmaceuticals announces successful USFDA inspection at Aleor Dermaceuticals'. Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals. (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has successfully cleared its first United States Food and Drugs Administration (USFDA) inspection of its new formulation manufacturing facility located at Karakhadi, Gujarat, India; without any observations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..